State Board of Administration of Florida Retirement System’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Buy
18,076
+4,171
+30% +$304K ﹤0.01% 1149
2026
Q1
$701K Buy
13,905
+4,875
+54% +$184K ﹤0.01% 1397
2025
Q4
$296K Buy
+9,030
New +$236K ﹤0.01% 1761
2025
Q1
Sell
-9,030
Closed -$210K 2213
2024
Q4
$210K Hold
9,030
﹤0.01% 1936
2024
Q3
$266K Hold
9,030
﹤0.01% 1853
2024
Q2
$212K Buy
+9,030
New +$305K ﹤0.01% 1929

Other funds holding SYRE

State Board of Administration of Florida Retirement System's SYRE Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System increased its Spyre Therapeutics (SYRE) stake by 30% in Q2 2026, buying an estimated $304K and bringing the position to 18,076 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

State Board of Administration of Florida Retirement System first reported a position in SYRE in Q2 2024 and has held it in 6 quarters since. 265 funds tracked by Wall St. Rank hold SYRE as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 18,076 shares of Spyre Therapeutics worth $1.6M as of Q2 2026.
  • State Board of Administration of Florida Retirement System bought 4,171 Spyre Therapeutics shares in Q2 2026, an estimated $304K.
  • Spyre Therapeutics made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1149 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Spyre Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 265 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.